Dunedin Income Growth In... Share Price (DIG)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Dunedin Income Growth Investment Trust Plc	LSE:DIG	London	Ordinary Share	GB0003406096	ORD 25P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-2.00p	-0.73%	273.00p	230,838	16:29:29

Bid Price		Offer Price	High Price	Low Price	Open Price
273.00p		276.00p	276.00p	273.00p	276.00p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Equity Investment Instruments	22.26	19.20	12.68	21.5	406.2

Related Shares
Scottish Mortgage Invest... (SMT), Etfs Phy Pm B � (PHPP), Tiger Resource (TIR), Energiser Investments (ENGI)

Dunedin Income Growth In... (DIG) Latest News (1)

Dunedin Income Growth In... News

Date	Time	Source	Headline
19/6/2019	11:59	UKREG	Dunedin Income Growth Inv Tst PLC Net Asset Value(s)
18/6/2019	12:20	UKREG	Dunedin Income Growth Inv Tst PLC Net Asset Value(s)
17/6/2019	12:20	UKREG	Dunedin Income Growth Inv Tst PLC Net Asset Value(s)
14/6/2019	15:56	UKREG	Dunedin Income Growth Inv Tst PLC Portfolio Disclosures
14/6/2019	13:22	UKREG	Dunedin Income Growth Inv Tst PLC Net Asset Value(s)
13/6/2019	14:53	UKREG	Dunedin Income Growth Inv Tst PLC First Interim Dividend
13/6/2019	11:44	UKREG	Dunedin Income Growth Inv Tst PLC Net Asset Value(s)
12/6/2019	15:07	UKREG	Dunedin Income Growth Inv Tst PLC Director/PDMR Shareholding
12/6/2019	12:10	UKREG	Dunedin Income Growth Inv Tst PLC Net Asset Value(s)
11/6/2019	12:43	UKREG	Dunedin Income Growth Inv Tst PLC Net Asset Value(s)

More Dunedin Income Growth In... News

Dunedin Income Growth In... Takeover Rumours

Dunedin Income Growth In... (DIG) Share Charts

1 Year Dunedin Income Growth In... Chart

1 Month Dunedin Income Growth In... Chart

Intraday Dunedin Income Growth In... Chart

Dunedin Income Growth In... (DIG) Discussions and Chat

Dunedin Income Growth In... Forums and Chat

Date	Time	Title	Posts
09/5/2019	20:38	DUNEDIN INCOME -A steady Income from the Aberdeen Stable	27
22/2/2014	15:21	2014: The turn around for the mining sector.	19
14/8/2008	19:50	The Great Digital Broadcast RipOff	-
04/11/2005	11:18	GET IN QUICK BEFORE THOSE 'KING MMS NOTICE!!!!!!!!	7

Add a New Thread

Dunedin Income Growth In... (DIG) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
16:35:31	273.00	10,000	27,300.00	O
15:35:13	273.00	15,760	43,024.80	UT
15:29:54	273.00	65	177.45	AT
15:29:29	273.00	48	131.04	AT
15:25:52	274.00	1,287	3,526.38	AT

View all Dunedin Income Growth In... trades in real-time

Dunedin Income Growth In... (DIG) Top Chat Posts

Date	Subject
19/6/2019 09:20	Dunedin Income Growth In... Daily Update: Dunedin Income Growth Investment Trust Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker DIG. The last closing price for Dunedin Income Growth In... was 275p. Dunedin Income Growth Investment Trust Plc has a 4 week average price of 262p and a 12 week average price of 253p. The 1 year high share price is 277p while the 1 year low share price is currently 228p. There are currently 148,784,898 shares in issue and the average daily traded volume is 94,352 shares. The market capitalisation of Dunedin Income Growth Investment Trust Plc is £406,182,771.54. Read Full Thread Reply
19/9/2018 11:51	speedsgh: from Fund Manager's Report in the latest Factsheet to 31/7/2018... The major share price movements within the portfolio were once again due to company specific events. French employee benefit and payments business Edenred increased sharply on the back of a very positive set of interim results, demonstrating the benefit of our overseas positioning in generating diverse and attractive investment opportunities. UK listed small cap life insurer Chesnara rebounded sharply on a broker upgrade that highlighted the significant discount to net assets and the attractive and growing dividend. Not owning Glencore also proved beneficial as the miner was hit by a potential US Department of Justice investigation into its conduct in a number of emerging markets. At a sector level oil companies lagged as hydrocarbon prices fell following a strong run since the start of the year amidst some concerns over rising US output. In contrast tobacco stocks continued to perform strongly, benefiting from solid results and a stronger dollar, partially reversing some of the very significant underperformance of the past twelve months. Pharmaceutical stocks also performed well primarily led by growing investor enthusiasm for AstraZeneca and their attractive revenue profile from new products. Activity remained relatively high as we continued to shift the portfolio towards better quality, higher growth and smaller companies. As a result we introduced new holdings in life sciences company Abcam and financial services provider London Stock Exchange. Both of these are lower yielding investments but offer the prospect of double digit dividend growth for many years ahead. Abcam is a world leading franchise specialising in the manufacture and distribution of antibodies used in scientific research. It has exceptional long–term growth prospects, a strong balance sheet and the potential to significantly increase their distributions to shareholders over time. London Stock Exchange has a very strong position in the provision of exchange, clearing, index and settlement services. This provides high and resilient levels of growth that should translate into attractive levels of dividend growth to its investors. We added further to positions in a number of mid-sized companies including Hansteen which owns a high yielding portfolio of industrial real estate, Assura the provider of primary care facilities across the UK and Aveva the leading design software provider for oil and gas, power and marine industries. At the larger end of the market cap spectrum we also increased our holding further in British American Tobacco, attracted by the elevated yield and resilient growth and National Grid where strong performance in their US assets increasingly underpins the high and steadily growing dividend. We trimmed our position in Experian given a stretched valuation following a significant increase in the share price on the back of positive results. We also exited our relatively small position in Swiss pharmaceutical giant Roche given lacklustre prospects for dividend growth and reduced our holding in HSBC where the growth outlook is also subdued and the yield no longer offers such an attractive premium to that achievable elsewhere. Our approach remains unchanged and we continue to focus on improving the medium term income and capital growth potential of the portfolio while maintaining appropriate diversity and balancing the near term requirements of our relatively high yield. Benefiting from the new combined research capabilities of the firm we have an increasingly full pipeline of attractive potential investments, particularly those focused toward capital and income growth. Finding higher yielding companies that we deem of sufficient quality for long-term investment is more challenging but we continue to evaluate a number of opportunities. All of which should allow us to position the portfolio in an increasingly differentiated manner, while underpinning the dividend policy. Equity markets remain relatively buoyant although there are a number of headwinds developing, particularly around global trade and the increasingly bellicose approach of the US to the implementation of sanctions on countries such as Turkey. As such we see little reason to shift from a conservative focus on higher quality businesses. While significant movements in large benchmark weighted stocks can affect near term relative performance, given changes to the portfolio and sound corporate performance we remain confident in the total return potential for the trust. Read Full Thread Follow Reply

Date

Subject

19/6/2019
09:20

Dunedin Income Growth In... Daily Update: Dunedin Income Growth Investment Trust Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker DIG. The last closing price for Dunedin Income Growth In... was 275p.
Dunedin Income Growth Investment Trust Plc has a 4 week average price of 262p and a 12 week average price of 253p.
The 1 year high share price is 277p while the 1 year low share price is currently 228p.
There are currently 148,784,898 shares in issue and the average daily traded volume is 94,352 shares. The market capitalisation of Dunedin Income Growth Investment Trust Plc is £406,182,771.54.

Read Full Thread

19/9/2018
11:51

speedsgh: from Fund Manager's Report in the latest Factsheet to 31/7/2018... The major share price movements within the portfolio were once again due to company specific events. French employee benefit and payments business Edenred increased sharply on the back of a very positive set of interim results, demonstrating the benefit of our overseas positioning in generating diverse and attractive investment opportunities. UK listed small cap life insurer Chesnara rebounded sharply on a broker upgrade that highlighted the significant discount to net assets and the attractive and growing dividend. Not owning Glencore also proved beneficial as the miner was hit by a potential US Department of Justice investigation into its conduct in a number of emerging markets. At a sector level oil companies lagged as hydrocarbon prices fell following a strong run since the start of the year amidst some concerns over rising US output. In contrast tobacco stocks continued to perform strongly, benefiting from solid results and a stronger dollar, partially reversing some of the very significant underperformance of the past twelve months. Pharmaceutical stocks also performed well primarily led by growing investor enthusiasm for AstraZeneca and their attractive revenue profile from new products. Activity remained relatively high as we continued to shift the portfolio towards better quality, higher growth and smaller companies. As a result we introduced new holdings in life sciences company Abcam and financial services provider London Stock Exchange. Both of these are lower yielding investments but offer the prospect of double digit dividend growth for many years ahead. Abcam is a world leading franchise specialising in the manufacture and distribution of antibodies used in scientific research. It has exceptional long–term growth prospects, a strong balance sheet and the potential to significantly increase their distributions to shareholders over time. London Stock Exchange has a very strong position in the provision of exchange, clearing, index and settlement services. This provides high and resilient levels of growth that should translate into attractive levels of dividend growth to its investors. We added further to positions in a number of mid-sized companies including Hansteen which owns a high yielding portfolio of industrial real estate, Assura the provider of primary care facilities across the UK and Aveva the leading design software provider for oil and gas, power and marine industries. At the larger end of the market cap spectrum we also increased our holding further in British American Tobacco, attracted by the elevated yield and resilient growth and National Grid where strong performance in their US assets increasingly underpins the high and steadily growing dividend. We trimmed our position in Experian given a stretched valuation following a significant increase in the share price on the back of positive results. We also exited our relatively small position in Swiss pharmaceutical giant Roche given lacklustre prospects for dividend growth and reduced our holding in HSBC where the growth outlook is also subdued and the yield no longer offers such an attractive premium to that achievable elsewhere. Our approach remains unchanged and we continue to focus on improving the medium term income and capital growth potential of the portfolio while maintaining appropriate diversity and balancing the near term requirements of our relatively high yield. Benefiting from the new combined research capabilities of the firm we have an increasingly full pipeline of attractive potential investments, particularly those focused toward capital and income growth. Finding higher yielding companies that we deem of sufficient quality for long-term investment is more challenging but we continue to evaluate a number of opportunities. All of which should allow us to position the portfolio in an increasingly differentiated manner, while underpinning the dividend policy. Equity markets remain relatively buoyant although there are a number of headwinds developing, particularly around global trade and the increasingly bellicose approach of the US to the implementation of sanctions on countries such as Turkey. As such we see little reason to shift from a conservative focus on higher quality businesses. While significant movements in large benchmark weighted stocks can affect near term relative performance, given changes to the portfolio and sound corporate performance we remain confident in the total return potential for the trust.

Read Full Thread

Dunedin Income Growth In... share price data is direct from the London Stock Exchange

Your Recent History

LSE

DIG

Dunedin In..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190619 19:14:36